[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]



March 28, 2019

Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients With Cancer: A Review

Abstract Full Text
JAMA Oncol. Published online March 28, 2019. doi:10.1001/jamaoncol.2019.0034

This review examines the main toxic effects of phosphatidylinositol 3-kinase inhibitors and recommends approaches to identification and management of such toxic effects.